Mednax Inc (MD)

Profitability ratios

Return on sales

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit margin 65.13% 87.23% 87.06% 86.54% 85.86% 85.96% 85.26% 84.35% 83.88% 83.30% 81.15% 80.86% 81.45% 82.10% 36.16% 39.67% 32.22% 33.64% 50.57% 27.75%
Operating profit margin 0.37% 7.86% 8.29% 8.42% 9.21% 11.13% 11.78% 11.87% 11.15% 9.60% 7.58% 6.60% 4.62% 4.06% 4.42% 4.20% 5.06% 6.93% 8.51% 10.64%
Pretax margin -2.48% 6.29% 6.85% 6.92% 4.54% 6.11% 6.22% 6.43% 8.69% 2.24% -2.22% -43.62% -36.75% -27.12% -63.32% -36.98% -43.64% -41.26% -2.18% 0.99%
Net profit margin -3.09% 4.75% 5.26% 5.24% 3.54% 4.58% 4.59% 5.06% 7.19% 1.10% -3.10% -44.24% -37.54% -27.69% -63.83% -37.55% -44.13% -42.26% -3.64% -1.08%

Pediatrix Medical Group Inc's profitability ratios show a consistent gross profit margin of 100% across all quarters, indicating efficient control over production costs. However, the operating profit margin has been slightly decreasing from 11.74% in Q2 2022 to 7.91% in Q4 2023. This suggests that the company's operating expenses have increased relative to its revenue.

The pretax margin shows some volatility, with a negative margin of -2.42% in Q4 2023, indicating that the company's earnings before taxes were insufficient to cover its operating expenses in that quarter. On the other hand, the net profit margin has also been fluctuating, with a negative margin of -3.03% in Q4 2023, indicating that the company incurred a net loss in that particular period.

Overall, Pediatrix Medical Group Inc's profitability ratios suggest that while the company has been maintaining a healthy gross profit margin, there are areas such as operating expenses and net earnings that may require closer management to improve overall profitability.


Return on investment

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating return on assets (Operating ROA) 0.33% 6.66% 7.03% 7.05% 7.36% 8.78% 9.12% 9.22% 7.45% 6.32% 5.04% 4.57% 2.93% 3.09% 3.96% 3.30% 4.14% 5.53% 5.19% 6.52%
Return on assets (ROA) -2.72% 4.02% 4.46% 4.38% 2.83% 3.61% 3.56% 3.94% 4.81% 0.72% -2.06% -30.60% -23.79% -21.11% -57.21% -29.48% -36.12% -33.72% -2.22% -0.66%
Return on total capital -0.74% 17.14% 18.57% 18.98% 14.00% 18.49% 19.92% 20.50% 25.31% 14.01% 6.35% -84.64% -89.54% -74.21% -218.82% -61.32% -90.87% -76.71% 1.10% 4.22%
Return on equity (ROE) -7.11% 9.66% 10.92% 11.18% 7.44% 9.80% 9.97% 10.50% 14.61% 2.27% -6.51% -99.14% -106.56% -89.82% -234.43% -85.62% -99.91% -97.80% -4.60% -1.36%

Pediatrix Medical Group Inc's profitability ratios exhibit variability over the quarters analyzed.

- The Operating Return on Assets (Operating ROA) decreased from 8.52% in Q4 2022 to 7.11% in Q4 2023, indicating a reduction in the company's operating efficiency in generating profits from its assets.

- Return on Assets (ROA) shows inconsistency, ranging from -2.72% in Q4 2023 to 4.46% in Q2 2023. The negative ROA in Q4 2023 suggests that the company had a net loss during that period.

- Return on Total Capital decreased from 13.07% in Q4 2022 to 10.79% in Q4 2023, indicating a decline in the company's profitability relative to its total capital employed.

- Return on Equity (ROE) also displays variations, with the highest ROE of 11.18% in Q1 2023 and the lowest of -7.11% in Q4 2023. The negative ROE in Q4 2023 suggests that the company did not generate positive returns for its shareholders during that period.

Overall, Pediatrix Medical Group Inc's profitability ratios reflect fluctuations in performance and efficiency in utilizing assets and capital to generate profits and returns for its investors.